JP2006158244A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006158244A5 JP2006158244A5 JP2004351903A JP2004351903A JP2006158244A5 JP 2006158244 A5 JP2006158244 A5 JP 2006158244A5 JP 2004351903 A JP2004351903 A JP 2004351903A JP 2004351903 A JP2004351903 A JP 2004351903A JP 2006158244 A5 JP2006158244 A5 JP 2006158244A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- protein
- amino acid
- sequence represented
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 claims 22
- 102000004169 proteins and genes Human genes 0.000 claims 20
- 125000003275 alpha amino acid group Chemical group 0.000 claims 16
- 102000039446 nucleic acids Human genes 0.000 claims 13
- 108020004707 nucleic acids Proteins 0.000 claims 13
- 150000007523 nucleic acids Chemical class 0.000 claims 13
- 230000003394 haemopoietic effect Effects 0.000 claims 10
- 230000001737 promoting effect Effects 0.000 claims 8
- 239000002773 nucleotide Substances 0.000 claims 7
- 125000003729 nucleotide group Chemical group 0.000 claims 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 4
- 238000012216 screening Methods 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 208000032467 Aplastic anaemia Diseases 0.000 claims 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010033661 Pancytopenia Diseases 0.000 claims 1
- 238000010322 bone marrow transplantation Methods 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 208000024389 cytopenia Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 238000001959 radiotherapy Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004351903A JP4696543B2 (ja) | 2004-12-03 | 2004-12-03 | 新規蛋白質、その医薬用途、その蛋白質の遺伝子のプロモーターおよびその用途 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004351903A JP4696543B2 (ja) | 2004-12-03 | 2004-12-03 | 新規蛋白質、その医薬用途、その蛋白質の遺伝子のプロモーターおよびその用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006158244A JP2006158244A (ja) | 2006-06-22 |
| JP2006158244A5 true JP2006158244A5 (https=) | 2008-01-24 |
| JP4696543B2 JP4696543B2 (ja) | 2011-06-08 |
Family
ID=36660894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004351903A Expired - Fee Related JP4696543B2 (ja) | 2004-12-03 | 2004-12-03 | 新規蛋白質、その医薬用途、その蛋白質の遺伝子のプロモーターおよびその用途 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4696543B2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0523373D0 (en) * | 2005-11-16 | 2005-12-28 | Ares Trading Sa | Nidogen/snep-like molecule |
| JPWO2011162115A1 (ja) * | 2010-06-21 | 2013-08-19 | 国立大学法人東京工業大学 | 膵臓β細胞増殖因子を利用した医薬組成物 |
| JP5888852B2 (ja) * | 2010-12-08 | 2016-03-22 | 学校法人近畿大学 | 免疫不全動物を用いた細胞の製法 |
-
2004
- 2004-12-03 JP JP2004351903A patent/JP4696543B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005520834A5 (https=) | ||
| ATE348883T1 (de) | Zusammensetzungen und verfahren mit analogen von g-csf | |
| JP2017018125A5 (https=) | ||
| JP2018138049A5 (https=) | ||
| JP2005516072A5 (https=) | ||
| RU2007105677A (ru) | Модифицированные витамин к-зависимые полипептиды | |
| ATE419537T1 (de) | Verwendung eines polypeptids zur auffindung von multipler sklerose | |
| JP2019536462A5 (https=) | ||
| JP2019534884A5 (https=) | ||
| CN104650210A (zh) | 作为体内造血刺激剂的tat-hoxb4h重组蛋白质的制备方法 | |
| JP2021532776A5 (https=) | ||
| JP2019500414A5 (https=) | ||
| JP2006502702A5 (https=) | ||
| CA2692358A1 (en) | Recombinant human interferon-like proteins | |
| JP2020127419A5 (https=) | ||
| JP2004536128A5 (https=) | ||
| JP2005512558A5 (https=) | ||
| EP1634892A3 (en) | Composition and methods for the diagnosis of tumours | |
| CA2202519A1 (en) | Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase | |
| JP2006158244A5 (https=) | ||
| JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
| JP2004535161A5 (https=) | ||
| CA2265500A1 (en) | Novel semaphorin gene: semaphorin y | |
| RU2006119452A (ru) | Рекомбинантный белок, обладающий противораковым действием, кодирующий его ген и его применение | |
| JP2003113111A5 (https=) |